INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION FOR TREATING CANCER

• 收藏
• 分享

专利权人:

INC.;SPECTRUM PHARMACEUTICALS

发明人:

LENAZ, LUIGI,CHAWLA, SHANTA,BEER, MARIO

申请号：

NZ57960908

公开号：

NZ579609A

申请日:

2008.03.13

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

Disclosed is a use of a therapeutic amount of apaziquone for manufacturing a medicament for administration within about 6 hours following transurethral resection of bladder tumour (TUR-BT) for treating a bladder cancer. Apaziquone is also known as E09 or NSC-382459 and is 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(1E)-3-hydroxyprop-1-enyl]-1-methyl-1H-indole-4,7-dione with the structural formula as depicted.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/